Evidence map›Paper›PMID 30207090›Full record

ArticleDrug testing and analysis2019

Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone).

Jose Luiz Costa, Kelly Francisco Cunha, Rafael Lanaro, Ricardo Leal Cunha, Donna Walther, Michael H Baumann

Open access · greenAbstract readCase Reports
In one paragraph

Article in Drug testing and analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. An updated review on synthetic cathinones.Archives of toxicology · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Interpol review of toxicology 2016-2019.Forensic science international. Synergy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jose Luiz CostaFaculty of Pharmaceutical Sciences, University of Campinas, Campinas, São Paulo, 13083-859, Brazil.ORCID http://orcid.org/0000-0001-9607-3391
Kelly Francisco CunhaCampinas Poison Control Center, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, 13083-859, Brazil.ORCID http://orcid.org/0000-0001-8078-3356
Rafael LanaroCampinas Poison Control Center, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, 13083-859, Brazil.ORCID http://orcid.org/0000-0003-1014-0974
Ricardo Leal CunhaInstitute of Chemistry, Federal University of Bahia, Salvador, Bahia, 40170-115, Brazil.ORCID http://orcid.org/0000-0003-0444-7742
Donna WaltherDesigner Drug Research Unit of the Intramural Research Program, National Institute on Drug Abuse (NIDA), National Institutes of Health, Baltimore, MD, USA.
Michael H BaumannDesigner Drug Research Unit of the Intramural Research Program, National Institute on Drug Abuse (NIDA), National Institutes of Health, Baltimore, MD, USA.
Universidade Estadual de Campinas (UNICAMP) · BRNational Institutes of Health · USUniversidade Federal da Bahia · BR

Funding

Studies on MDMA and Related CompoundsZIADA000523 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$16.4M
IMPROVING HEALTH CARE UTILIZATION IN HIV+ DRUG USERSK23DA000523 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2001 to 2005
$794k
Studies on MDMA and Related CompoundsZ01DA000523 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI ROTHMAN, RICHARD · 2008 to 2008
$199k
Conselho Nacional de Desenvolvimento Científico e Tecnológico 830525/1999-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/10650-8 and 2018/00432-1Intramural NIH HHS Z01 DA000523Intramural NIH HHS ZIA DA000523Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health DA 00523 to MHBNIDA NIH HHS K23 DA000523
6 · The paper itself

Abstract

Synthetic cathinones continue to proliferate in clandestine drug markets worldwide. N-ethylnorpentylone (also known as N-ethylpentylone or ephylone) is a popular emergent cathinone, yet little information is available about its toxicology and pharmacology. Here we characterize the analytical quantification, clinical presentation, and pharmacological mechanism of action for N-ethylnorpentylone. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) was used to quantify N-ethylnorpentylone in blood obtained from human cases. Clinical features exhibited by the intoxicated individuals are described. The activity of N-ethylnorpentylone at plasma membrane transporters for dopamine (DAT), norepinephrine (NET) and 5-HT (SERT) was assessed using in vitro assays measuring uptake inhibition and evoked release of [

Indexed as

AdolescentAdultAnimalsBenzodioxolesButylaminesCentral Nervous System StimulantsChromatography, LiquidDopamine Uptake InhibitorsFemaleHumansLimit of DetectionMaleNorepinephrine Plasma Membrane Transport ProteinsRatsReproducibility of ResultsSelective Serotonin Reuptake InhibitorsBenzodioxolesButylaminesCentral Nervous System StimulantsDopamine Uptake InhibitorsN-ethylpentyloneNorepinephrine Plasma Membrane Transport ProteinsSelective Serotonin Reuptake Inhibitorsforensic toxicologyliquid chromatography-tandem mass spectrometrymonoamine transporternew psychoactive substancessynthetic cathinone

Identifiers

PMID30207090
PMCPMC7316160
OpenAlexW2890761655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.